CN112469422A - 卤素化合物用于治疗和预防组织损伤和重症护理后综合征的用途 - Google Patents

卤素化合物用于治疗和预防组织损伤和重症护理后综合征的用途 Download PDF

Info

Publication number
CN112469422A
CN112469422A CN201980049776.3A CN201980049776A CN112469422A CN 112469422 A CN112469422 A CN 112469422A CN 201980049776 A CN201980049776 A CN 201980049776A CN 112469422 A CN112469422 A CN 112469422A
Authority
CN
China
Prior art keywords
iodide
injury
individual
disease
primary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201980049776.3A
Other languages
English (en)
Chinese (zh)
Inventor
史蒂芬·A·希尔
马克·B·罗思
约翰·W·兰斯顿
迈克尔·L·莫里森
岩田明子
迈克尔·安德鲁·因斯科
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Faraday Pharmaceutical Co
Fred Hutchinson Cancer Center
Original Assignee
Faraday Pharmaceutical Co
Fred Hutchinson Cancer Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faraday Pharmaceutical Co, Fred Hutchinson Cancer Center filed Critical Faraday Pharmaceutical Co
Publication of CN112469422A publication Critical patent/CN112469422A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201980049776.3A 2018-06-08 2019-06-07 卤素化合物用于治疗和预防组织损伤和重症护理后综合征的用途 Pending CN112469422A (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201862682574P 2018-06-08 2018-06-08
US62/682,574 2018-06-08
US201862730927P 2018-09-13 2018-09-13
US201862730945P 2018-09-13 2018-09-13
US62/730,945 2018-09-13
US62/730,927 2018-09-13
PCT/US2019/036154 WO2019237065A1 (en) 2018-06-08 2019-06-07 Use of halogen compounds for the treatment and prevention of tissue injury and post-intensive care syndrome

Publications (1)

Publication Number Publication Date
CN112469422A true CN112469422A (zh) 2021-03-09

Family

ID=68770655

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980049776.3A Pending CN112469422A (zh) 2018-06-08 2019-06-07 卤素化合物用于治疗和预防组织损伤和重症护理后综合征的用途

Country Status (10)

Country Link
US (1) US20210252047A1 (https=)
EP (1) EP3801565A4 (https=)
JP (1) JP2021527130A (https=)
KR (1) KR20210018898A (https=)
CN (1) CN112469422A (https=)
AU (1) AU2019282820A1 (https=)
CA (1) CA3102792A1 (https=)
IL (1) IL279221A (https=)
MX (1) MX2020013306A (https=)
WO (1) WO2019237065A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX386702B (es) 2014-02-10 2025-03-19 Fred Hutchinson Cancer Center Tratamiento con halogeno de ataque cardiaco y lesion isquemica.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106102836A (zh) * 2014-02-10 2016-11-09 弗雷德哈钦森癌症研究中心 心脏病发作和缺血性损伤的卤素治疗

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248335B1 (en) * 1997-10-29 2001-06-19 Symbollon Corporation Stabilized oral pharmaceutical composition containing iodide and iodate and method
CZ295765B6 (cs) * 1998-07-29 2005-10-12 Apa - Praha, S.R.O. Léčebný přípravek s virucidním účinkem
GB0525504D0 (en) * 2005-12-14 2006-01-25 Bristol Myers Squibb Co Antimicrobial composition

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106102836A (zh) * 2014-02-10 2016-11-09 弗雷德哈钦森癌症研究中心 心脏病发作和缺血性损伤的卤素治疗

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
无: "Faraday announces start of FDY-5301 study", 《APN AMERICAN PHARMACY NEWS,HTTPS://AMERICANPHARMACYNEWS.COM/STORIES/511013260-FARADAY-ANNOUNCES-START-OF-FDY-5301-STUDY》 *

Also Published As

Publication number Publication date
AU2019282820A1 (en) 2021-01-21
CA3102792A1 (en) 2019-12-12
KR20210018898A (ko) 2021-02-18
EP3801565A4 (en) 2022-04-06
JP2021527130A (ja) 2021-10-11
EP3801565A1 (en) 2021-04-14
US20210252047A1 (en) 2021-08-19
MX2020013306A (es) 2021-05-12
WO2019237065A1 (en) 2019-12-12
IL279221A (en) 2021-01-31

Similar Documents

Publication Publication Date Title
US12016880B2 (en) Halogen treatment of heart attack and ischemic injury
BR112013005907B1 (pt) Composição farmacêutica parenteral
RU2561040C2 (ru) Фармацевтические композиции для лечения воспалительных заболеваний кишечника (взк)
EA017359B1 (ru) Способ и композиция для достижения бронхиальной релаксации
CN107519159A (zh) 复方组合物
WO2023023192A1 (en) IMMEDIATE RELEASE FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS
US20220395480A1 (en) Suspensions and diluents for metronidazole and baclofen
US20230149296A1 (en) Drug delivery system for the delivery of antiviral agents and contraceptives
CN112469422A (zh) 卤素化合物用于治疗和预防组织损伤和重症护理后综合征的用途
WO2021257806A1 (en) Iodide for treatment of nonthyroidal illness syndrome
CN108125940B (zh) 戊酸在制备用于预防和/或治疗肿瘤放疗副反应的药物中的用途
US20150290240A1 (en) Compositions comprising chalcogenides and related matters
CN1090491A (zh) 预防及治疗脓毒症的方法
JP2006160607A (ja) 局所麻酔薬物含有ゼリー剤
Gangwar et al. Development and evaluation of biodegradable floating drug delivery for solubility enhancement of diclofenac sodium
HK1231000B (en) Treatment of heart attack and ischemic injury with sodium iodide
HK1231000A1 (en) Treatment of heart attack and ischemic injury with sodium iodide
JPH07501076A (ja) 次サリチル酸ビスマスの単位剤形
CN101234096A (zh) 匹多莫德胶囊制剂及其制备方法
Rawlins et al. FORMULATION OF A READILY PREPARED D‐PENICILLAMINE ORAL LIQUID
CN107970248A (zh) 异甘草酸在制备治疗高血压药物中的用途
JP2011074090A (ja) リドカイン含有ゼリー剤

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20210309